This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
as well as | 720 |
the use of | 701 |
the presence of | 569 |
the development of | 418 |
in patients with | 385 |
in order to | 338 |
the number of | 333 |
the treatment of | 284 |
the detection of | 276 |
due to the | 260 |
one of the | 258 |
of the study | 213 |
severe acute respiratory | 207 |
acute respiratory syndrome | 202 |
for the detection | 192 |
a number of | 191 |
the production of | 191 |
the immune system | 188 |
in the presence | 187 |
based on the | 186 |
human immunodeficiency virus | 179 |
aim of the | 176 |
in addition to | 174 |
can be used | 173 |
the effect of | 171 |
the risk of | 169 |
in this study | 167 |
for the treatment | 166 |
of the antibody | 164 |
the role of | 164 |
it has been | 164 |
red blood cells | 163 |
of patients with | 157 |
human monoclonal antibodies | 156 |
be used to | 151 |
according to the | 145 |
to evaluate the | 145 |
been shown to | 144 |
the absence of | 141 |
of blood components | 139 |
the identification of | 135 |
to determine the | 135 |
of the immune | 135 |
a total of | 132 |
of the blood | 132 |
of this study | 131 |
the aim of | 130 |
well as the | 129 |
of the virus | 128 |
human monoclonal antibody | 128 |
found to be | 127 |
the surface of | 126 |
the results of | 126 |
the quality of | 124 |
because of the | 123 |
a variety of | 123 |
the immune response | 120 |
there is a | 120 |
the level of | 119 |
immunodeficiency virus type | 119 |
the generation of | 118 |
the frequency of | 117 |
the efficacy of | 116 |
and characterization of | 116 |
of monoclonal antibodies | 115 |
the need for | 114 |
has been shown | 113 |
present in the | 109 |
of blood donors | 109 |
the importance of | 108 |
such as the | 107 |
the majority of | 107 |
used for the | 107 |
study was to | 106 |
antibodies in the | 105 |
red blood cell | 105 |
on the surface | 104 |
blood and blood | 104 |
in the treatment | 104 |
has also been | 103 |
the ability of | 103 |
of the most | 103 |
there is no | 102 |
in vitro and | 101 |
the case of | 101 |
compared to the | 100 |
the end of | 99 |
the fact that | 99 |
the incidence of | 99 |
that can be | 98 |
can also be | 98 |
shown to be | 98 |
systemic lupus erythematosus | 98 |
respiratory syncytial virus | 98 |
some of the | 97 |
the prevalence of | 96 |
was used to | 96 |
most of the | 95 |
the binding of | 95 |
respiratory syndrome coronavirus | 94 |
associated with the | 94 |
the amount of | 94 |
analysis of the | 94 |
in the case | 94 |
at room temperature | 94 |
in contrast to | 93 |
of blood products | 93 |
as a result | 93 |
was found to | 92 |
heavy and light | 92 |
is associated with | 92 |
of blood transfusion | 91 |
there was no | 91 |
of the disease | 91 |
in terms of | 91 |
and in vivo | 91 |
for h at | 90 |
weak d type | 90 |
for detection of | 90 |
antibody responses to | 90 |
in the absence | 89 |
the prevention of | 89 |
the lack of | 89 |
of the patients | 87 |
were able to | 86 |
this study was | 86 |
the ability to | 86 |
a result of | 86 |
is the most | 86 |
related to the | 86 |
the formation of | 84 |
have shown that | 84 |
the implementation of | 84 |
used in the | 83 |
the most common | 83 |
have been developed | 83 |
immune response to | 82 |
the united states | 82 |
in recent years | 82 |
in the serum | 82 |
in transfusion medicine | 81 |
the course of | 81 |
to be a | 81 |
for the development | 81 |
development of a | 81 |
in the last | 81 |
on the other | 80 |
the addition of | 80 |
of the human | 80 |
and treatment of | 80 |
monoclonal antibodies against | 79 |
were detected in | 79 |
role in the | 79 |
blood transfusion service | 79 |
cd t cells | 79 |
phage display technology | 78 |
in the first | 78 |
is based on | 78 |
of blood and | 77 |
broadly neutralizing antibodies | 77 |
the pathogenesis of | 77 |
has not been | 77 |
in combination with | 77 |
part of the | 77 |
vitro and in | 77 |
as compared to | 77 |
in the united | 76 |
have also been | 76 |
monoclonal antibodies to | 76 |
with respect to | 76 |
which can be | 75 |
for the prevention | 75 |
memory b cells | 74 |
were tested for | 74 |
understanding of the | 74 |
in the blood | 73 |
the basis of | 73 |
it is possible | 73 |
involved in the | 73 |
of antibodies to | 73 |
the expression of | 72 |
aim of this | 72 |
depending on the | 72 |
of the antibodies | 72 |
end of the | 72 |
binding to the | 72 |
a range of | 72 |
the introduction of | 71 |
of whole blood | 71 |
the safety of | 71 |
to assess the | 71 |
the s protein | 71 |
the other hand | 71 |
the possibility of | 70 |
the percentage of | 70 |
herpes simplex virus | 70 |
from patients with | 70 |
to reduce the | 69 |
an increase in | 69 |
need to be | 69 |
was carried out | 69 |
be used for | 69 |
in response to | 69 |
showed that the | 69 |
the purpose of | 68 |
by phage display | 68 |
was found in | 68 |
the time of | 68 |
specificity of the | 68 |
has been reported | 67 |
in the past | 67 |
as shown in | 67 |
surface plasmon resonance | 67 |
in the future | 66 |
was used for | 65 |
the availability of | 65 |
used as a | 65 |
the rate of | 65 |
a panel of | 65 |
to increase the | 64 |
in the same | 64 |
in blood donors | 64 |
cells in the | 64 |
antibodies can be | 64 |
be due to | 64 |
can lead to | 64 |
the management of | 64 |
nature of the | 64 |
of antibodies in | 64 |
identification of the | 64 |
found in the | 63 |
and blood products | 63 |
to be the | 63 |
the diagnosis of | 63 |
the antibody response | 63 |
be used in | 63 |
appears to be | 63 |
were found in | 63 |
patients with severe | 63 |
to investigate the | 62 |
phage display library | 62 |
the specificity of | 62 |
have been used | 62 |
increase in the | 62 |
and in the | 62 |
the sensitivity of | 61 |
be used as | 61 |
of severe acute | 61 |
was observed in | 61 |
fresh frozen plasma | 61 |
for treatment of | 61 |
likely to be | 61 |
use of a | 61 |
due to their | 60 |
for min at | 60 |
a and b | 60 |
compared with the | 60 |
of a single | 60 |
was shown to | 60 |
on the basis | 60 |
data not shown | 59 |
directed against the | 59 |
hepatitis c virus | 59 |
large number of | 59 |
of an antibody | 59 |
can be detected | 59 |
a combination of | 58 |
have been shown | 58 |
is one of | 58 |
was used as | 58 |
the most frequent | 58 |
the cell surface | 58 |
use of blood | 58 |
antibodies to the | 57 |
the effectiveness of | 57 |
led to the | 57 |
material and methods | 57 |
of infectious diseases | 57 |
none of the | 57 |
the context of | 57 |
hepatitis b virus | 56 |
materials and methods | 56 |
the combination of | 56 |
the distribution of | 56 |
the effects of | 56 |
at the time | 56 |
linked immunosorbent assay | 56 |
in the development | 56 |
high levels of | 56 |
of convalescent plasma | 56 |
the induction of | 56 |
of the same | 56 |
associated with a | 56 |
the determination of | 56 |
specific for the | 56 |
of the patient | 56 |
the study of | 56 |
and it is | 56 |
west nile virus | 56 |
the nature of | 55 |
in some cases | 55 |
well as in | 55 |
a role in | 55 |
may not be | 55 |
the potential for | 55 |
a decrease in | 55 |
was detected in | 55 |
the impact of | 55 |
it is important | 55 |
shown in fig | 54 |
antibodies against the | 54 |
the serum of | 54 |
antibody response to | 54 |
the isolation of | 54 |
blood samples were | 54 |
the interaction of | 54 |
the onset of | 54 |
that of the | 54 |
are associated with | 54 |
in the s | 53 |
the levels of | 53 |
has been demonstrated | 53 |
the range of | 53 |
evaluation of the | 53 |
their ability to | 53 |
could be used | 53 |
the discovery of | 53 |
of antibodies against | 53 |
in clinical trials | 53 |
of the first | 53 |
of the igg | 53 |
at the same | 53 |
in the context | 53 |
and respiratory syndrome | 52 |
polymerase chain reaction | 52 |
the cost of | 52 |
by means of | 52 |
neutralizing monoclonal antibodies | 52 |
this study is | 52 |
to be used | 52 |
and light chain | 52 |
antibody to the | 52 |
included in the | 52 |
in which the | 52 |
addition to the | 52 |
before and after | 51 |
in case of | 51 |
were carried out | 51 |
in relation to | 51 |
were used to | 51 |
were found to | 51 |
are able to | 51 |
of human immunodeficiency | 51 |
was performed by | 51 |
in the study | 51 |
it is also | 51 |
a group of | 51 |
antibodies were detected | 51 |
for use in | 51 |
during the first | 51 |
of neutralizing antibodies | 50 |
samples were taken | 50 |
of red blood | 50 |
the selection of | 50 |
it is not | 50 |
be associated with | 50 |
virus infection in | 50 |
patients with sle | 50 |
the alternative pathway | 50 |
of antibody to | 50 |
structure of the | 50 |
of blood donation | 50 |
to identify the | 50 |
be able to | 49 |
sensitivity of the | 49 |
reproductive and respiratory | 49 |
for patients with | 49 |
there has been | 49 |
in animal models | 49 |
were positive for | 49 |
activation of the | 49 |
of intravenous immunoglobulin | 49 |
for the production | 49 |
no significant difference | 49 |
of monoclonal antibody | 49 |
of these antibodies | 49 |
the type of | 49 |
phage display libraries | 49 |
of the viral | 49 |
prevention and treatment | 48 |
study is to | 48 |
between the two | 48 |
response to the | 48 |
may also be | 48 |
binding of the | 48 |
the same time | 48 |
have not been | 48 |
differences in the | 48 |
were used for | 48 |
added to the | 48 |
all of the | 48 |
porcine reproductive and | 48 |
and of the | 48 |
igm and igg | 48 |
the most important | 48 |
this is a | 48 |
the last years | 48 |
the outcome of | 47 |
passive transfer of | 47 |
immune responses to | 47 |
use of the | 47 |
infection in the | 47 |
was able to | 47 |
to ensure that | 47 |
a monoclonal antibody | 47 |
one of these | 47 |
a series of | 47 |
in the table | 47 |
it can be | 46 |
antibodies have been | 46 |
was determined by | 46 |
the present study | 46 |
the field of | 46 |
the loss of | 46 |
needs to be | 46 |
was performed using | 46 |
have been reported | 46 |
results of the | 46 |
the need to | 46 |
were shown to | 46 |
is essential for | 46 |
for the first | 46 |
are shown in | 46 |
by flow cytometry | 46 |
the heavy chain | 46 |
the duration of | 46 |
in the number | 46 |
is possible to | 46 |
it may be | 46 |
for the presence | 46 |
characterization of a | 45 |
in the field | 45 |
the administration of | 45 |
bind to the | 45 |
used to detect | 45 |
derived from the | 45 |
of therapeutic antibodies | 45 |
tumor necrosis factor | 45 |
there was a | 45 |
have to be | 45 |
and can be | 45 |
of the sars | 45 |
it should be | 45 |
considered to be | 45 |
in the pathogenesis | 45 |
seems to be | 45 |
cd and cd | 44 |
the proportion of | 44 |
wide range of | 44 |
regulatory t cells | 44 |
a large number | 44 |
for prevention of | 44 |
incubated for h | 44 |
critically ill patients | 44 |
igg and igm | 44 |
has been used | 44 |
in a single | 44 |
for up to | 44 |
detected in the | 44 |
to improve the | 44 |
direct antiglobulin test | 44 |
of the anti | 44 |
could not be | 44 |
at the end | 44 |
were added to | 44 |
of the two | 44 |
the concentration of | 43 |
been used to | 43 |
important role in | 43 |
as a consequence | 43 |
neutralizing antibodies against | 43 |
significantly higher in | 43 |
monoclonal antibodies that | 43 |
a mixture of | 43 |
and safety of | 43 |
is an important | 43 |
blood donors and | 43 |
may be a | 43 |
is important to | 43 |
and light chains | 43 |
total number of | 43 |
of the antigen | 43 |
resulted in a | 43 |
with regard to | 43 |
neutralizing human monoclonal | 43 |
similar to the | 43 |
of red cell | 42 |
the severity of | 42 |
as previously described | 42 |
chain variable fragment | 42 |
many of the | 42 |
regions of the | 42 |
changes in the | 42 |
contribute to the | 42 |
is due to | 42 |
the degree of | 42 |
a wide range | 42 |
in the following | 42 |
the design of | 42 |
the potential to | 42 |
at least one | 42 |
it was shown | 42 |
an important role | 42 |
been shown that | 41 |
antibodies directed against | 41 |
of the total | 41 |
the blood transfusion | 41 |
of hepatitis b | 41 |
blood transfusion services | 41 |
of transfusion medicine | 41 |
the mechanism of | 41 |
monoclonal antibodies from | 41 |
region of the | 41 |
respiratory syndrome virus | 41 |
demonstrated that the | 41 |
monoclonal antibodies in | 41 |
the application of | 41 |
presence of the | 41 |
studies of the | 41 |
morbidity and mortality | 41 |
in these patients | 40 |
chicken egg yolk | 40 |
the potential of | 40 |
has to be | 40 |
potent neutralization of | 40 |
of a novel | 40 |
up to days | 40 |
approved by the | 40 |
effect of the | 40 |
because of their | 40 |
blood donors in | 40 |
monoclonal antibody to | 40 |
study of the | 40 |
responsible for the | 40 |
for the generation | 40 |
a reduction in | 40 |
in spite of | 40 |
t cells and | 40 |
in the early | 40 |
antibodies against sars | 40 |
the interaction between | 40 |
in accordance with | 40 |
each of the | 40 |
identification of a | 40 |
feline infectious peritonitis | 40 |
used as the | 39 |
is likely to | 39 |
in comparison to | 39 |
antibody in the | 39 |
to that of | 39 |
humoral immune response | 39 |
due to a | 39 |
to bind to | 39 |
in of the | 39 |
expression of the | 39 |
it is a | 39 |
as in the | 39 |
appear to be | 39 |
quality of the | 39 |
an average of | 39 |
the activation of | 39 |
has been developed | 39 |
lead to a | 39 |
as part of | 39 |
with a high | 39 |
antibody responses in | 39 |
the phage display | 39 |
influenza a virus | 39 |
any of the | 39 |
results suggest that | 39 |
number of blood | 39 |
of the s | 39 |
in cases of | 39 |
the occurrence of | 38 |
that have been | 38 |
dependent on the | 38 |
antibody response in | 38 |
a human monoclonal | 38 |
the release of | 38 |
sensitivity and specificity | 38 |
a review of | 38 |
carried out in | 38 |
of phage display | 38 |
convalescent plasma therapy | 38 |
blood components and | 38 |
for in vivo | 38 |
depends on the | 38 |
in this review | 38 |
the basis for | 38 |
of the donors | 38 |
positive for anti | 38 |
were collected from | 38 |
there were no | 38 |
in the group | 38 |
and blood components | 38 |
of platelet concentrates | 38 |
for more than | 38 |
the study was | 38 |
suggest that the | 38 |
for at least | 37 |
effect on the | 37 |
wang et al | 37 |
the blood bank | 37 |
years of age | 37 |
the analysis of | 37 |
results show that | 37 |
antibodies specific for | 37 |
are the most | 37 |
have been identified | 37 |
of the target | 37 |
h n influenza | 37 |
the two groups | 37 |
of an anti | 37 |
colostrum and milk | 37 |
in the second | 37 |
was significantly higher | 37 |
was performed in | 37 |
a patient with | 37 |
were used as | 37 |
with or without | 37 |
referred to as | 37 |
the emergence of | 36 |
chimeric antigen receptor | 36 |
in patients undergoing | 36 |
were incubated with | 36 |
tm platelet kit | 36 |
as described above | 36 |
the period of | 36 |
characterization of the | 36 |
presence of a | 36 |
platelets stored at | 36 |
clinical and laboratory | 36 |
is a major | 36 |
of a human | 36 |
control of the | 36 |
was shown that | 36 |
may be more | 36 |
the group of | 36 |
blood donors are | 36 |
leading to the | 36 |
the affinity of | 36 |
and that the | 36 |
to have a | 36 |
the total number | 36 |
scansystem tm platelet | 36 |
egg yolk antibodies | 36 |
may lead to | 36 |
in this case | 36 |
characteristics of the | 36 |
be involved in | 35 |
antibodies that are | 35 |
on the cell | 35 |
known to be | 35 |
the possibility that | 35 |
than that of | 35 |
b cells and | 35 |
the activity of | 35 |
for the determination | 35 |
by using a | 35 |
observed in the | 35 |
development of the | 35 |
differences between the | 35 |
in of patients | 35 |
food and drug | 35 |
bacterial contamination of | 35 |
growth factor receptor | 35 |
the results were | 35 |
the cells were | 35 |
days after the | 35 |
our understanding of | 35 |
there are several | 35 |
but it is | 35 |
of our study | 35 |
different types of | 35 |
the concept of | 34 |
studies have shown | 34 |
this is the | 34 |
in the control | 34 |
the size of | 34 |
they can be | 34 |
of the use | 34 |
is used to | 34 |
is used for | 34 |
the significance of | 34 |
we found that | 34 |
due to anti | 34 |
monoclonal antibody against | 34 |
the results are | 34 |
immune responses in | 34 |
of the clinical | 34 |
is mediated by | 34 |
purpose of this | 34 |
of the method | 34 |
may be used | 34 |
be detected in | 34 |
of the assay | 34 |
is used in | 34 |
of a new | 34 |
of b cells | 34 |
and incubated for | 34 |
more likely to | 34 |
size of the | 34 |
of escherichia coli | 34 |
the in vitro | 34 |
the v loop | 34 |
large numbers of | 34 |
obtained from the | 34 |
reported to be | 34 |
course of the | 33 |
over the last | 33 |
determination of the | 33 |
members of the | 33 |
the process of | 33 |
to prevent the | 33 |
of the newborn | 33 |
of the plasma | 33 |
the performance of | 33 |
and for the | 33 |
based on a | 33 |
b and c | 33 |
and drug administration | 33 |
in the production | 33 |
nieri et al | 33 |
the neutralization of | 33 |
the sera of | 33 |
for the diagnosis | 33 |
were incubated for | 33 |
cells infected with | 33 |
western blot analysis | 33 |
the prevention and | 33 |
to the same | 33 |
of the protein | 33 |
led to a | 33 |
as a potential | 33 |
positive results were | 33 |
by use of | 33 |
for blood transfusion | 33 |
than in the | 33 |
neutralizing antibodies in | 33 |
presence of anti | 33 |
of the results | 33 |
with the use | 33 |
antibody phage display | 33 |
caused by the | 33 |
in a mouse | 33 |
in all the | 33 |
the goal of | 33 |
shown in table | 33 |
to determine whether | 33 |
are summarized in | 33 |
small number of | 33 |
was higher in | 33 |
the in vivo | 33 |
the result of | 33 |
world health organization | 32 |
role of the | 32 |
difference in the | 32 |
of immune complexes | 32 |
of nucleic acid | 32 |
knowledge of the | 32 |
igm and iga | 32 |
in the present | 32 |
patients with a | 32 |
as early as | 32 |
there have been | 32 |
in our study | 32 |
on the use | 32 |
should not be | 32 |
be detected by | 32 |
of the cell | 32 |
suggesting that the | 32 |
a positive result | 32 |
human b cells | 32 |
the day of | 32 |
patients who have | 32 |
with the same | 32 |
safety of the | 32 |
isolation and characterization | 32 |
and identification of | 32 |
which is a | 32 |
been reported in | 32 |
with the exception | 32 |
was added to | 32 |
of broadly neutralizing | 32 |
remains to be | 32 |
of maternal antibodies | 32 |
in comparison with | 32 |
intravenous immune globulin | 32 |
monoclonal antibodies and | 32 |
for infectious diseases | 32 |
for the same | 32 |
domain of the | 31 |
the mechanisms of | 31 |
in both groups | 31 |
of antibodies and | 31 |
autologous blood donation | 31 |
in our hospital | 31 |
period of time | 31 |
there are many | 31 |
a systematic review | 31 |
also be used | 31 |
council of europe | 31 |
b cells in | 31 |
and incubated at | 31 |
disease of the | 31 |
safety of blood | 31 |
after the first | 31 |
and development of | 31 |
of up to | 31 |
were analyzed by | 31 |
the most potent | 31 |
mabs have been | 31 |
of more than | 31 |
single domain antibodies | 31 |
the relationship between | 31 |
lead to the | 31 |
on the day | 31 |
in the laboratory | 31 |
the blood donors | 31 |
by using the | 31 |
the exception of | 31 |
units of blood | 31 |
the results obtained | 31 |
contrast to the | 31 |
of recombinant antibodies | 31 |
t cells in | 31 |
components of the | 31 |
blood group system | 31 |
to study the | 31 |
was performed on | 31 |
of the positive | 31 |
e and e | 31 |
of these patients | 31 |
of factor viii | 31 |
efficacy and safety | 31 |
from whole blood | 31 |
specific monoclonal antibodies | 31 |
of specific antibodies | 31 |
when compared to | 31 |
samples were tested | 30 |
there is an | 30 |
conjugated goat anti | 30 |
of the hiv | 30 |
during the study | 30 |
in conjunction with | 30 |
weak d types | 30 |
escherichia coli o | 30 |
in the human | 30 |
patients in the | 30 |
of the host | 30 |
in the sample | 30 |
with the median | 30 |
that may be | 30 |
performance of the | 30 |
were used in | 30 |
results in the | 30 |
in the transfusion | 30 |
antibody titers were | 30 |
the consumption of | 30 |
the safety and | 30 |
half of the | 30 |
that there is | 30 |
shown that the | 30 |
some of these | 30 |
activity of the | 30 |
the preparation of | 30 |
respiratory distress syndrome | 30 |
intravenous immunoglobulin therapy | 30 |
responses to sars | 30 |
in out of | 30 |
of hbv infection | 30 |
to the virus | 30 |
is the first | 30 |
derived from a | 30 |
followed by a | 30 |
a history of | 30 |
the volume of | 30 |
of the fc | 30 |
an immune response | 30 |
it is likely | 30 |
to detect the | 30 |
the influence of | 30 |
to respond to | 30 |
balb c mice | 30 |
were treated with | 30 |
is caused by | 30 |
in the uk | 30 |
of immune responses | 30 |
transmissible gastroenteritis virus | 30 |
comparison of the | 30 |
of sars coronavirus | 30 |
more than one | 30 |
vh and vl | 30 |
that do not | 30 |
is related to | 30 |
prior to the | 30 |
were performed in | 30 |
studies on the | 30 |
in the usa | 30 |
broadly neutralizing antibody | 29 |
are required to | 29 |
in the a | 29 |
the initiation of | 29 |
onset of symptoms | 29 |
suggests that the | 29 |
quality of blood | 29 |
in the prevention | 29 |
in this work | 29 |
to provide a | 29 |
resulted in the | 29 |
and stored at | 29 |
cells of the | 29 |
reduce the risk | 29 |
of the phage | 29 |
detection of antibodies | 29 |
the control group | 29 |
out of the | 29 |
central nervous system | 29 |
development of new | 29 |
the host immune | 29 |
the advantage of | 29 |
of bispecific antibodies | 29 |
of human monoclonal | 29 |
the reduction of | 29 |
the reasons for | 29 |
the site of | 29 |
hla class i | 29 |
quality of life | 29 |
of them were | 29 |
the cause of | 29 |
of antibodies that | 29 |
in whole blood | 29 |
in the mouse | 29 |
the complement system | 29 |
monoclonal antibodies were | 29 |
to the use | 29 |
in serum and | 29 |
this study we | 29 |
dose intravenous immunoglobulin | 29 |
at least two | 29 |
virus in the | 29 |
the first time | 29 |
from the same | 29 |
which may be | 29 |
is not known | 29 |
and efficacy of | 29 |
and the mean | 29 |
by a single | 29 |
indicate that the | 29 |
of the other | 29 |
similar to that | 29 |
together with the | 29 |
immune response in | 29 |
an alternative to | 29 |
as an alternative | 29 |
the blood supply | 29 |
and has been | 29 |
in the us | 29 |
and duration of | 29 |
did not show | 29 |
neutralizing activity of | 28 |
diagnostic and therapeutic | 28 |
these results suggest | 28 |
to define the | 28 |
indirect antiglobulin test | 28 |
ensure that the | 28 |
may be due | 28 |
specific antibodies were | 28 |
by western blot | 28 |
the success of | 28 |
has been found | 28 |
were obtained from | 28 |
the control of | 28 |
significant difference in | 28 |
relationship between the | 28 |
can result in | 28 |
using phage display | 28 |
also known as | 28 |
was obtained from | 28 |
it has also | 28 |
use in the | 28 |
bound to the | 28 |
expressed on the | 28 |
this may be | 28 |
which is the | 28 |
in the range | 28 |
are needed to | 28 |
are used to | 28 |
with ml of | 28 |
shown in the | 28 |
been found to | 28 |
a phage display | 28 |
distribution of blood | 28 |
amino acid residues | 28 |
crystal structure of | 28 |
in the immune | 28 |
and the use | 28 |
was the first | 28 |
has led to | 28 |
the form of | 28 |
development of an | 28 |
of the cases | 28 |
to be associated | 28 |
the target cell | 28 |
days of storage | 28 |
have been described | 28 |
red cell concentrates | 28 |
g for min | 28 |
safe and effective | 28 |
ministry of health | 28 |
of the national | 28 |
during the last | 28 |
results in a | 28 |
defined as the | 28 |
this can be | 28 |
neonatal fc receptor | 28 |
the limitations of | 28 |
that the use | 28 |
are capable of | 28 |
of the different | 28 |
intensive care unit | 28 |
the feasibility of | 28 |
the capacity to | 28 |
able to detect | 28 |
of antibody in | 27 |
from the blood | 27 |
should be considered | 27 |
the advantages of | 27 |
resulting in the | 27 |
carried out by | 27 |
the function of | 27 |
the human immune | 27 |
of the complement | 27 |
of the population | 27 |
of influenza virus | 27 |
has been the | 27 |
isolated from a | 27 |
function of the | 27 |
data suggest that | 27 |
to the development | 27 |
of bacterial contamination | 27 |
of plasmodium falciparum | 27 |
was identified in | 27 |
is capable of | 27 |
immune response against | 27 |
which has been | 27 |
an increase of | 27 |
positive and negative | 27 |
cd binding site | 27 |
number of patients | 27 |
s and s | 27 |
in the form | 27 |
in the detection | 27 |
have been found | 27 |
result of the | 27 |
the adaptive immune | 27 |
transfusion medicine is | 27 |
aspects of the | 27 |
can be achieved | 27 |
with a single | 27 |
the capacity of | 27 |
that in the | 27 |
well as to | 27 |
and in vitro | 27 |
were subjected to | 27 |
is necessary to | 27 |
in a patient | 27 |
is required for | 27 |
most of these | 27 |
transfusion service in | 27 |
have been observed | 27 |
this suggests that | 27 |
national blood transfusion | 27 |
and patients with | 27 |
in critically ill | 27 |
immune system and | 27 |
be applied to | 27 |
are presented in | 27 |
results indicate that | 27 |
the route of | 27 |
were observed in | 27 |
to develop a | 27 |
by the addition | 27 |
mhc class i | 27 |
implementation of the | 27 |
neonatal alloimmune thrombocytopenia | 27 |
we conclude that | 27 |
in blood transfusion | 27 |
the blood donation | 27 |
decrease in the | 27 |
was confirmed by | 27 |
were isolated from | 26 |
east respiratory syndrome | 26 |
of antibody and | 26 |
was associated with | 26 |
as determined by | 26 |
the last two | 26 |
passive immunity in | 26 |
neutralization of sars | 26 |
all rights reserved | 26 |
the antibodies were | 26 |
of neutralizing antibody | 26 |
to present the | 26 |
passive immunization with | 26 |
at risk for | 26 |
were associated with | 26 |
innate and adaptive | 26 |
to monitor the | 26 |
sequence of the | 26 |
the red blood | 26 |
there is evidence | 26 |
the patient was | 26 |
low levels of | 26 |
the choice of | 26 |
can be found | 26 |
recognition of the | 26 |
of bone marrow | 26 |
correlates of protection | 26 |
could be a | 26 |
by the end | 26 |
with systemic lupus | 26 |
the fc region | 26 |
diseases such as | 26 |
of the toxin | 26 |
is that the | 26 |
and management of | 26 |
middle east respiratory | 26 |
epidermal growth factor | 26 |
the screening of | 26 |
a study of | 26 |
that it is | 26 |
were performed on | 26 |
for transfusion medicine | 26 |
of the serum | 26 |
a mouse model | 26 |
supported by the | 26 |
was isolated from | 26 |
dependent cellular cytotoxicity | 26 |
to the m | 26 |
in mice and | 26 |
was performed with | 26 |
of these studies | 26 |
of the donor | 26 |
required for the | 26 |
for cancer therapy | 26 |
infection of the | 26 |
to the blood | 26 |
for the identification | 26 |
specific antibody responses | 26 |
and igg antibodies | 25 |
of measles virus | 25 |
transfusion therapy in | 25 |
blood donation is | 25 |
for identification of | 25 |
due to its | 25 |
the virus in | 25 |
sera from patients | 25 |
in the sera | 25 |
of patients who | 25 |
been developed to | 25 |
this has been | 25 |
the existence of | 25 |
the probability of | 25 |
in clinical practice | 25 |
is difficult to | 25 |
not associated with | 25 |
can be applied | 25 |
intravenous immunoglobulin for | 25 |
the transfer of | 25 |
an in vitro | 25 |
of the organism | 25 |
of red cells | 25 |
a subset of | 25 |
on day and | 25 |
focused on the | 25 |
for binding to | 25 |
with high affinity | 25 |
detection of the | 25 |
member of the | 25 |
cd monoclonal antibody | 25 |
ability of the | 25 |
show that the | 25 |
of viral infections | 25 |
is expected to | 25 |
are likely to | 25 |
in our blood | 25 |
followed by the | 25 |
this article is | 25 |
during the course | 25 |
can be made | 25 |
potent neutralizing antibodies | 25 |
and to the | 25 |
in systemic lupus | 25 |
assessment of the | 25 |
to the target | 25 |
corresponding to the | 25 |
of which were | 25 |
in the population | 25 |
ranged from to | 25 |
majority of the | 25 |
mediated by the | 25 |
the filamentous phage | 25 |
can be a | 25 |
been reported to | 25 |
that they are | 25 |
data indicate that | 25 |
well as a | 25 |
it is the | 25 |
did not affect | 25 |
that bind to | 25 |
quality control of | 25 |
acute lung injury | 25 |
well as for | 25 |
reduction of the | 25 |
be the most | 25 |
after blood donation | 25 |
initiation of the | 25 |
relation to the | 25 |
voluntary blood donors | 25 |
results can be | 25 |
the spread of | 25 |
a pool of | 25 |
is important for | 25 |
aim of our | 25 |
antibodies from a | 25 |
monoclonal antibodies for | 25 |
the national blood | 25 |
clinical trials for | 25 |
the evaluation of | 25 |
cells and the | 25 |
is dependent on | 25 |
response to a | 25 |
to the cell | 25 |
a set of | 25 |
there are no | 25 |
detection of a | 24 |
of the three | 24 |
with a mean | 24 |
are known to | 24 |
been used in | 24 |
especially in the | 24 |
and have been | 24 |
molecules per rbc | 24 |
the objective of | 24 |
had to be | 24 |
and it was | 24 |
case of a | 24 |
abo blood group | 24 |
protective effect of | 24 |
one or more | 24 |
dependent enhancement of | 24 |
it was not | 24 |
blood components is | 24 |
higher than that | 24 |
can be obtained | 24 |
by monoclonal antibodies | 24 |
advantages and disadvantages | 24 |
play a role | 24 |
stored for days | 24 |
many of these | 24 |
is not a | 24 |
blood donors were | 24 |
of the procedure | 24 |
cells can be | 24 |
blood banking and | 24 |
the value of | 24 |
cytotoxic t cells | 24 |
a lack of | 24 |
to those of | 24 |
result in the | 24 |
has the potential | 24 |
review of the | 24 |
in pregnant women | 24 |
of igg and | 24 |
and the other | 24 |
seen in the | 24 |
the differences in | 24 |
major histocompatibility complex | 24 |
focus on the | 24 |
patients with covid | 24 |
cov spike protein | 24 |
did not differ | 24 |
amino acid sequence | 24 |
up to of | 24 |
small amounts of | 24 |
the growth of | 24 |
the extent of | 24 |
for the study | 24 |
to the presence | 24 |
similar to those | 24 |
c and anti | 24 |
of the major | 24 |
may be the | 24 |
hiv and hcv | 24 |
of b cell | 24 |
blood donors who | 24 |
in the plasma | 24 |
was tested in | 24 |
these antibodies are | 24 |
shown to have | 24 |
to enhance the | 24 |
the collection of | 24 |
as shown by | 24 |
as described previously | 24 |
bone marrow transplantation | 24 |
for disease control | 24 |
have been proposed | 24 |
the most effective | 24 |
banking and transfusion | 24 |
the first to | 24 |
it could be | 24 |
the samples were | 24 |
number of igg | 24 |
surface of the | 24 |
of the vaccine | 24 |
epitopes on the | 24 |
in the course | 24 |
was positive in | 24 |
of influenza a | 24 |
short period of | 24 |
is shown in | 23 |
statistically significant difference | 23 |
was measured by | 23 |
in which a | 23 |
were selected for | 23 |
of a given | 23 |
of antibody responses | 23 |
only a few | 23 |
in the diagnosis | 23 |
three times with | 23 |
linked to the | 23 |
of the potential | 23 |
who did not | 23 |
and the development | 23 |
a recent study | 23 |
as for the | 23 |
of infected cells | 23 |
the difference in | 23 |
purpose of the | 23 |
also been used | 23 |
in blood donation | 23 |
blood donors is | 23 |
for the isolation | 23 |
they do not | 23 |
the world health | 23 |
therapeutic monoclonal antibodies | 23 |
treatment of severe | 23 |
with the development | 23 |
to donate blood | 23 |
mechanism of action | 23 |
higher in the | 23 |
ranging from to | 23 |
efficacy of a | 23 |
of mumps virus | 23 |
transfusion medicine and | 23 |
in the literature | 23 |
innate lymphoid cells | 23 |
blood donation and | 23 |
were determined by | 23 |
respect to the | 23 |
of the current | 23 |
blood collection and | 23 |
clinical use of | 23 |
are present in | 23 |
of dengue virus | 23 |
of the heavy | 23 |
specific to the | 23 |
not yet been | 23 |
antibodies and the | 23 |
has been proposed | 23 |
antibodies has been | 23 |
antibody binding to | 23 |
haemolytic disease of | 23 |
by addition of | 23 |
abo and rh | 23 |
as the most | 23 |
isolated from the | 23 |
a and anti | 23 |
of patients and | 23 |
were significantly higher | 23 |
used to identify | 23 |
proven to be | 23 |
to be involved | 23 |
patients with systemic | 23 |
can be generated | 23 |
the diagnosis and | 23 |
and quality of | 23 |
it would be | 23 |
suggested that the | 23 |
of allogeneic blood | 23 |
of the test | 23 |
only a small | 23 |
was to evaluate | 23 |
is the only | 23 |
the first step | 23 |
to understand the | 23 |
hepatitis b surface | 23 |
of t cells | 23 |
study showed that | 23 |
be difficult to | 23 |
we did not | 23 |
the plates were | 23 |
the neutralizing activity | 23 |
presence of antibody | 23 |
the diversity of | 23 |
the light chain | 23 |
basis for the | 23 |
in ml of | 23 |
the innate immune | 23 |
affinity of the | 23 |
efficacy of the | 23 |
in this regard | 23 |
provided by the | 23 |
was supported by | 23 |
mechanisms of action | 23 |
were taken from | 23 |
no effect on | 23 |
portion of the | 23 |
the authors declare | 23 |
is responsible for | 23 |
monoclonal antibody that | 23 |
a single dose | 23 |
and western blot | 23 |
in many cases | 23 |
that the number | 23 |
found that the | 23 |
in a study | 23 |
present on the | 23 |
of complement activation | 23 |
able to neutralize | 23 |
immune system is | 23 |
the immunogenicity of | 23 |
is defined as | 22 |
volume of the | 22 |
t cell responses | 22 |
antibodies may be | 22 |
m and m | 22 |
that could be | 22 |
for blood donation | 22 |
be found in | 22 |
in vivo expression | 22 |
of the red | 22 |
the humoral immune | 22 |
was observed with | 22 |
specific cd t | 22 |
serum and milk | 22 |
ana lysis of | 22 |
consistent with the | 22 |
of infectious disease | 22 |
are expected to | 22 |
c and c | 22 |
could be detected | 22 |
such as a | 22 |
were stored at | 22 |
of the b | 22 |
we have been | 22 |
hbv infection in | 22 |
limited number of | 22 |
increased risk of | 22 |
systematic review and | 22 |
evaluation of a | 22 |
a high level | 22 |
is a significant | 22 |
patients suffering from | 22 |
determined by the | 22 |
reduction in the | 22 |
difference between the | 22 |
detected in cases | 22 |
an increased risk | 22 |
in vitro studies | 22 |
the beginning of | 22 |
our study was | 22 |
blood transfusion and | 22 |
it was found | 22 |
group of patients | 22 |
to achieve a | 22 |
be achieved by | 22 |
to the viral | 22 |
and function of | 22 |
single chain variable | 22 |
is possible that | 22 |
described in the | 22 |
a dose of | 22 |
antibodies that bind | 22 |
mhc class ii | 22 |
n influenza virus | 22 |
used in this | 22 |
and incubated with | 22 |
been developed for | 22 |
of a large | 22 |
immunosensor for the | 22 |
and monoclonal antibodies | 22 |
the construction of | 22 |
a concentration of | 22 |
quality and safety | 22 |
in all cases | 22 |
in patients who | 22 |
the patients with | 22 |
high level of | 22 |
at least in | 22 |
is a common | 22 |
was assessed by | 22 |
based on their | 22 |
in the identification | 22 |
produced by the | 22 |
as a model | 22 |
and did not | 22 |
blood banks and | 22 |
immunity in the | 22 |
a period of | 22 |
are available for | 22 |
results of a | 22 |
antibodies in a | 22 |
severity of the | 22 |
in the management | 22 |
the finding that | 22 |
were measured in | 22 |
out of patients | 22 |
tests were performed | 22 |
for this reason | 22 |
of in vivo | 22 |
formation of a | 22 |
from phage display | 22 |
the b cell | 22 |
staphylococcal enterotoxin b | 22 |
the monoclonal antibody | 22 |
to the identification | 22 |
site of the | 22 |
results were obtained | 22 |
from blood donors | 22 |
by the use | 22 |
have demonstrated that | 22 |
impact on the | 22 |
in the world | 22 |
the host cell | 22 |
and type of | 22 |
monoclonal antibody therapy | 22 |
h n virus | 22 |
igg and igg | 22 |
with monoclonal antibodies | 22 |
is similar to | 22 |
the negative control | 22 |
more than of | 22 |
attributed to the | 22 |
are involved in | 22 |
blood products in | 22 |
is involved in | 22 |
recent advances in | 22 |
the past years | 22 |
of egg yolk | 22 |
to be effective | 22 |
depend on the | 22 |
specificity and affinity | 22 |
indicated that the | 22 |
animal models of | 22 |
more than a | 22 |
two or more | 22 |
widely used in | 22 |
li et al | 21 |
of an antigen | 21 |
there are two | 21 |
to the c | 21 |
carried out using | 21 |
is present in | 21 |
therapeutic efficacy of | 21 |
was seen in | 21 |
is clear that | 21 |
order to prevent | 21 |
immune responses and | 21 |
indicates that the | 21 |
blood mononuclear cells | 21 |
the red cell | 21 |
thought to be | 21 |
for the use | 21 |
in infectious diseases | 21 |
to generate a | 21 |
a negative control | 21 |
in a murine | 21 |
the mortality rate | 21 |
to the sars | 21 |
d type was | 21 |
blood in the | 21 |
in children with | 21 |
to meet the | 21 |
a mean of | 21 |
prophylactic and therapeutic | 21 |
order to evaluate | 21 |
duration of the | 21 |
but not in | 21 |
of the v | 21 |
blood products and | 21 |
the last decade | 21 |
of the selected | 21 |
only in the | 21 |
of systemic lupus | 21 |
antigens in the | 21 |
is characterized by | 21 |
in most cases | 21 |
for infectious disease | 21 |
the transmission of | 21 |
higher than the | 21 |
immune response of | 21 |
safety and efficacy | 21 |
it seems that | 21 |
blood products is | 21 |
antibody responses and | 21 |
of the main | 21 |
antibody directed against | 21 |
hbsag and anti | 21 |
of units of | 21 |
patients who are | 21 |
by electron microscopy | 21 |
information about the | 21 |
to protect against | 21 |
of all the | 21 |
of the mechanisms | 21 |
of safe blood | 21 |
a consequence of | 21 |
and analysis of | 21 |
most of them | 21 |
can be performed | 21 |
this group of | 21 |
to be more | 21 |
yet to be | 21 |
would like to | 21 |
to confirm the | 21 |
the response to | 21 |
males and females | 21 |
the general population | 21 |
high sensitivity and | 21 |
properties of the | 21 |
incubated with the | 21 |
of the complex | 21 |
through the use | 21 |
whether or not | 21 |
neutralizing antibodies and | 21 |
it is clear | 21 |
in the neutralization | 21 |
polyclonal and monoclonal | 21 |
specific antibodies in | 21 |
been used for | 21 |
of the rhd | 21 |
the council of | 21 |
simultaneous detection of | 21 |
shown in figure | 21 |
adaptive immune system | 21 |
first time blood | 21 |
attached to the | 21 |
of hepatitis c | 21 |
rhd gamma globulin | 21 |
were due to | 21 |
application of the | 21 |
serum samples were | 21 |
peripheral blood mononuclear | 21 |
in the antibody | 21 |
blood units were | 21 |
probably due to | 21 |
be related to | 21 |
patients and the | 21 |
has been made | 21 |
was present in | 21 |
the efficiency of | 21 |
treatment of infectious | 21 |
of a positive | 21 |
iga antibodies in | 21 |
structural basis for | 21 |
of antibodies from | 21 |
guidelines for the | 21 |
significant increase in | 21 |
it was also | 21 |
therapy in patients | 21 |
samples were collected | 21 |
the most commonly | 21 |
the median being | 21 |
our blood centre | 21 |
were obtained by | 21 |
or in combination | 21 |
clinical signs of | 21 |
and should be | 21 |
increase of the | 21 |
antibody to pca | 21 |
the same epitope | 21 |
and immunogenicity of | 21 |
column agglutination technology | 21 |
of the fetus | 21 |
mechanism by which | 21 |
of novel coronavirus | 21 |
to react with | 21 |
has been suggested | 21 |
of plasma and | 21 |
in humans and | 21 |
antibodies from the | 21 |
according to their | 21 |
stem cell transplantation | 21 |
and weak d | 21 |
specific antibodies to | 21 |
assay for the | 21 |
on the contrary | 21 |
in a dose | 20 |
may result in | 20 |
blood donation was | 20 |
neutralizing activity against | 20 |
binding site of | 20 |
to each well | 20 |
blood group antigens | 20 |
was extracted from | 20 |
of igg antibodies | 20 |
of antibody fragments | 20 |
blood samples from | 20 |
the efficacy and | 20 |
associated with high | 20 |
adaptive immune responses | 20 |
the kinetics of | 20 |
fc fusion proteins | 20 |
effects of the | 20 |
while in the | 20 |
also been reported | 20 |
patients treated with | 20 |
applied to the | 20 |
had a positive | 20 |
cp e epitope | 20 |
for diagnosis of | 20 |
not detected in | 20 |
that the antibody | 20 |
igg and iga | 20 |
mediated effector functions | 20 |
in this way | 20 |
of the world | 20 |
this work was | 20 |
natural killer cells | 20 |
washed three times | 20 |
humoral and cellular | 20 |
over the past | 20 |
phage display and | 20 |
component of the | 20 |
by the fact | 20 |
can be produced | 20 |
the cd binding | 20 |
summarized in the | 20 |
were more likely | 20 |
times with pbs | 20 |
made in the | 20 |
acute respiratory distress | 20 |
the gastrointestinal tract | 20 |
a small number | 20 |
antibody specific for | 20 |
epitopes of the | 20 |
is required to | 20 |
but also to | 20 |
igy against the | 20 |
mouse model of | 20 |
no evidence of | 20 |
not react with | 20 |
performed in the | 20 |
of the high | 20 |
an antibody response | 20 |
we were able | 20 |
and h n | 20 |
limit of detection | 20 |
white blood cells | 20 |
times higher than | 20 |
and cd t | 20 |
interpretation of the | 20 |
from a single | 20 |
the monoclonal antibodies | 20 |
was found between | 20 |
monoclonal antibodies with | 20 |
be present in | 20 |
of human igg | 20 |
immunosensor based on | 20 |
been demonstrated that | 20 |
of infection and | 20 |
the delivery of | 20 |
b surface antigen | 20 |
was treated with | 20 |
were included in | 20 |
protection of the | 20 |
demonstration of the | 20 |
to neutralize the | 20 |
to test the | 20 |
cell lung cancer | 20 |
used as an | 20 |
it is known | 20 |
antibody titers in | 20 |
the t cell | 20 |
the blood group | 20 |
of bacterial infections | 20 |
the patients who | 20 |
antibodies produced by | 20 |
for antibodies against | 20 |
in treatment of | 20 |
play an important | 20 |
use of convalescent | 20 |
identified in the | 20 |
large amounts of | 20 |
it possible to | 20 |
activities of the | 20 |
and absence of | 20 |
state of the | 20 |
the removal of | 20 |
and the results | 20 |
result in a | 20 |
the potency of | 20 |
as low as | 20 |
of bacteria in | 20 |
revealed that the | 20 |
proved to be | 20 |
of which are | 20 |
that had been | 20 |
has been a | 20 |
were negative for | 20 |
for their ability | 20 |
immune system to | 20 |
in red cell | 20 |
in association with | 20 |
antibodies for the | 20 |
although it is | 20 |
risk of transfusion | 20 |
the quality and | 20 |
the transfusion of | 20 |
the inhibition of | 20 |
advantage of the | 20 |
patients with primary | 20 |
did not have | 20 |
be expected to | 20 |
low level of | 20 |
was detected by | 20 |
ml of the | 19 |
and at the | 19 |
contamination of blood | 19 |
the population of | 19 |
is protected by | 19 |
of porcine reproductive | 19 |
as high as | 19 |
and do not | 19 |
mutations on the | 19 |
the university of | 19 |
with that of | 19 |
correlated with the | 19 |
performed as described | 19 |
and production of | 19 |
and the most | 19 |
antibody titers against | 19 |
in view of | 19 |
leads to the | 19 |
approximately of the | 19 |
diagnosis and treatment | 19 |
with the presence | 19 |
and may be | 19 |
as measured by | 19 |
to be at | 19 |
not affect the | 19 |
it does not | 19 |
may contribute to | 19 |
formation of the | 19 |
were confirmed by | 19 |
were transfused with | 19 |
a function of | 19 |
the pattern of | 19 |
has been to | 19 |
red cell units | 19 |
to compare the | 19 |
bone marrow transplant | 19 |
of the n | 19 |
and specificity of | 19 |
and transfusion medicine | 19 |
added to each | 19 |
of transfusion reactions | 19 |
of adverse events | 19 |
based on these | 19 |
protective efficacy of | 19 |
antibodies isolated from | 19 |
to protect the | 19 |
immunoglobulin therapy in | 19 |
of fused cells | 19 |
whole blood units | 19 |
the measurement of | 19 |
to of the | 19 |
iga and igm | 19 |
were infected with | 19 |
detection of hepatitis | 19 |
in blood components | 19 |
development of therapeutic | 19 |
months of age | 19 |
resulting in a | 19 |
of immunoglobulin g | 19 |
for the preparation | 19 |
the indirect antiglobulin | 19 |
advantage of this | 19 |
s protein and | 19 |
blood was collected | 19 |
were tested by | 19 |
the first week | 19 |
measurement of the | 19 |
were detected by | 19 |
which could be | 19 |
the respiratory tract | 19 |
neutralizing antibodies to | 19 |
to determine if | 19 |
during this period | 19 |
a novel coronavirus | 19 |
located in the | 19 |
tested for their | 19 |
these results are | 19 |
generation of a | 19 |
in escherichia coli | 19 |
tested for the | 19 |
in our center | 19 |
intravenous immunoglobulin in | 19 |
of the efficacy | 19 |
in a variety | 19 |
and could be | 19 |
is supported by | 19 |
it is therefore | 19 |
last few years | 19 |
conclude that the | 19 |
detection of antibody | 19 |
in blood donor | 19 |
to the cd | 19 |
in sera from | 19 |
will be presented | 19 |
h at room | 19 |
bound to a | 19 |
been reported that | 19 |
as to the | 19 |
have been approved | 19 |
innate immune system | 19 |
on the s | 19 |
be a useful | 19 |
some of them | 19 |
in many countries | 19 |
will be discussed | 19 |
combinatorial antibody libraries | 19 |
structural and functional | 19 |
a change in | 19 |
cp e antibody | 19 |
the hypothesis that | 19 |
are used for | 19 |
mouse monoclonal antibodies | 19 |
of these proteins | 19 |
the failure of | 19 |
patients with chronic | 19 |
in the routine | 19 |
blood donation in | 19 |
clinically significant antibodies | 19 |
of this approach | 19 |
hepatitis b and | 19 |
the nonneutralized fraction | 19 |
shows that the | 19 |
an overview of | 19 |
human immunoglobulin g | 19 |
to be positive | 19 |
antibodies against hiv | 19 |
and adaptive immune | 19 |
blood donor screening | 19 |
this is an | 19 |
not only to | 19 |
but did not | 19 |
the department of | 19 |
for development of | 19 |
oral administration of | 19 |
influenza virus infection | 19 |
the sera from | 19 |
nucleic acid testing | 19 |
of the agent | 19 |
receptor binding domain | 19 |
human b cell | 19 |
be considered in | 19 |
after the onset | 19 |
preoperative autologous blood | 19 |
is likely that | 19 |
because there is | 19 |
of antibody production | 19 |
have the potential | 19 |
the most sensitive | 19 |
evidence for a | 19 |
a phase i | 19 |
but also in | 19 |
that the blood | 19 |
than of the | 19 |
the classical pathway | 19 |
of the animals | 19 |
viral load in | 19 |
use of this | 19 |
high frequency of | 19 |
the association between | 19 |
to establish a | 19 |
of blood in | 19 |
wnv e protein | 19 |
in vivo and | 19 |
it will be | 19 |
neutralizing antibody titers | 19 |
the structure of | 19 |
of plasma derivates | 18 |
of hbv dna | 18 |
as far as | 18 |
viruses such as | 18 |
in this area | 18 |
the epidemiology of | 18 |
for the rapid | 18 |
helical coiled coil | 18 |
primary and secondary | 18 |
frequency of the | 18 |
count and the | 18 |
for the blood | 18 |
animals treated with | 18 |
a significantly higher | 18 |
one or two | 18 |
of a specific | 18 |
number of the | 18 |
as described in | 18 |
continuous cultures of | 18 |
the scope of | 18 |
the mixture was | 18 |
the cell membrane | 18 |
host immune response | 18 |
effective use of | 18 |
the increase in | 18 |
the virus and | 18 |
was significantly lower | 18 |
of the immunoglobulin | 18 |
fused cells secreting | 18 |
free fetal dna | 18 |
mean age of | 18 |
the patient and | 18 |
was used in | 18 |
repeat blood donors | 18 |
number of different | 18 |
a comparison of | 18 |
the heavy and | 18 |
article is protected | 18 |
method for the | 18 |
to overcome these | 18 |
of the cd | 18 |
are responsible for | 18 |
as long as | 18 |
a source of | 18 |
of herpes simplex | 18 |
has recently been | 18 |
infected cells in | 18 |
directed to the | 18 |
such as those | 18 |
has been widely | 18 |
of fresh frozen | 18 |
report of the | 18 |
is not yet | 18 |
with enzyme treated | 18 |
generation and characterization | 18 |
cd t cell | 18 |
for hbv dna | 18 |
in the formation | 18 |
zhang et al | 18 |
chain variable fragments | 18 |
of infectious virus | 18 |
and severity of | 18 |
should be performed | 18 |
expression of a | 18 |
and purification of | 18 |
the contribution of | 18 |
systemic and mucosal | 18 |
in agreement with | 18 |
in serum or | 18 |
more frequently in | 18 |
high concentrations of | 18 |
side of the | 18 |
epitope on the | 18 |
of human origin | 18 |
therapeutic potential of | 18 |
is referred to | 18 |
is critical for | 18 |
we describe the | 18 |
of serum antibody | 18 |
detected in serum | 18 |
igg molecules per | 18 |
recognized by the | 18 |
of specific antibody | 18 |
of a blood | 18 |
positive samples were | 18 |
the fusion of | 18 |
for determination of | 18 |
the protection of | 18 |
of detection of | 18 |
with severe acute | 18 |
components and blood | 18 |
immune response and | 18 |
the neonatal fc | 18 |
human antibody repertoire | 18 |
that the most | 18 |
to the surface | 18 |
in the near | 18 |
the study period | 18 |
is an effective | 18 |
for weak d | 18 |
antibodies that neutralize | 18 |
standard operating procedures | 18 |
protected by copyright | 18 |
cause of the | 18 |
a blood donor | 18 |
from the circulation | 18 |
of respiratory syncytial | 18 |
human immune system | 18 |
for antibody screening | 18 |
the characteristics of | 18 |
who have been | 18 |
was to determine | 18 |
response in the | 18 |
of in vitro | 18 |
experiments were performed | 18 |
of weak d | 18 |
its ability to | 18 |
two types of | 18 |
binds to the | 18 |
detection of escherichia | 18 |
and b cells | 18 |
the method of | 18 |
cultures of fused | 18 |
a retrospective study | 18 |
of autologous blood | 18 |
be divided into | 18 |
patients with multiple | 18 |
enl and enl | 18 |
the inh titre | 18 |
a fully human | 18 |
a case of | 18 |
results showed that | 18 |
to the number | 18 |
antibodies against a | 18 |
laboratory diagnosis of | 18 |
have been transfused | 18 |
red cell transfusion | 18 |
platelet count and | 18 |
is essential to | 18 |
the quantity of | 18 |
the same period | 18 |
to days after | 18 |
early in the | 18 |
the early s | 18 |
infection in mice | 18 |
monoclonal antibodies are | 18 |
identification and characterization | 18 |
on the same | 18 |
of a monoclonal | 18 |
the donation of | 18 |
induced by the | 18 |
of the control | 18 |
use of phage | 18 |
from memory b | 18 |
c and e | 18 |
can be divided | 18 |
to a single | 18 |
obtained by the | 18 |
mabs can be | 18 |
for antibody production | 18 |
the virus was | 18 |
the autovue innova | 18 |
form of the | 18 |
the antibody was | 18 |
the observation that | 18 |
the scansystem tm | 18 |
objective of this | 18 |
of the c | 18 |
may have been | 18 |
and application of | 18 |
of rabies virus | 18 |
antibodies of the | 18 |
the magnitude of | 18 |
the likelihood of | 18 |
in cases with | 18 |
broad spectrum of | 18 |
by the presence | 18 |
a broad spectrum | 18 |
for blood and | 18 |
was based on | 18 |
in platelets stored | 18 |
are tested for | 18 |
in the majority | 18 |
the complexity of | 18 |
the appearance of | 18 |
of the mouse | 18 |
antibody and the | 18 |
in rheumatoid arthritis | 18 |
of the present | 18 |
in vivo in | 18 |
optimised scansystem tm | 18 |
cell free fetal | 18 |
samples from the | 18 |
the peripheral blood | 18 |
with a low | 18 |
in the clinical | 18 |
h d mutation | 18 |
room temperature for | 18 |
the treatment and | 18 |
of blood banks | 18 |
caused by a | 18 |
we report the | 18 |
of the infection | 18 |
in the final | 18 |
of buffy coat | 18 |
construction of a | 18 |
of botulinum neurotoxin | 18 |
in the period | 18 |
in blood and | 18 |
preparation of blood | 18 |
endothelial growth factor | 18 |
to blood transfusion | 18 |
at this time | 18 |
essential for the | 17 |
passive immunity to | 17 |
b cell receptor | 17 |
of the second | 17 |
treatment of cancer | 17 |
of s protein | 17 |
antibody to a | 17 |
for clinical use | 17 |
toxic shock syndrome | 17 |
part of a | 17 |
were collected and | 17 |
it appears that | 17 |
from a phage | 17 |
testing of the | 17 |
and as a | 17 |
of infection in | 17 |
recombinant antibody fragments | 17 |
the mmr vaccine | 17 |
it is difficult | 17 |
these antibodies were | 17 |
is in the | 17 |
light chain variable | 17 |
of a vaccine | 17 |
and control of | 17 |
of a patient | 17 |
the reactivity of | 17 |
mutations in the | 17 |
the s and | 17 |
of transmissible gastroenteritis | 17 |
in one case | 17 |
antibody titers of | 17 |
reactivity of the | 17 |
production of antibodies | 17 |
and therapy of | 17 |
interaction of the | 17 |
prevalence of anti | 17 |
the age of | 17 |
their use in | 17 |
fully human antibodies | 17 |
in another study | 17 |
the length of | 17 |
to patients with | 17 |
be useful for | 17 |
antibodies derived from | 17 |
the decision to | 17 |
and the antibody | 17 |
be important in | 17 |
appeared to be | 17 |
been associated with | 17 |
are unable to | 17 |
days after challenge | 17 |
as effective as | 17 |
h n and | 17 |
yeast surface display | 17 |
of them have | 17 |
blood safety and | 17 |
epitopes in the | 17 |
the enhancement of | 17 |
and the first | 17 |
tested in a | 17 |
of the new | 17 |
there is also | 17 |
antibody and complement | 17 |
may be associated | 17 |
has not yet | 17 |
blood products for | 17 |
for vaccine development | 17 |
activity in the | 17 |
the last few | 17 |
mice infected with | 17 |
all of these | 17 |
basis of the | 17 |
and the clinical | 17 |
the specificity and | 17 |
was performed as | 17 |
proteins on the | 17 |
diagnosis and therapy | 17 |
an animal model | 17 |
centers for disease | 17 |
connective tissue disease | 17 |
to note that | 17 |
insights into the | 17 |
of the monoclonal | 17 |
monoclonal antibody in | 17 |
age of the | 17 |
results from the | 17 |
view of the | 17 |
higher prevalence of | 17 |
antibodies with the | 17 |
false positive results | 17 |
in the area | 17 |
can be isolated | 17 |
for the last | 17 |
observed that the | 17 |
methods for the | 17 |
contact with the | 17 |
the consequences of | 17 |
the sars coronavirus | 17 |
was designed to | 17 |
this results in | 17 |
antibody against the | 17 |
no significant differences | 17 |
the whole blood | 17 |
step in the | 17 |
for blood collection | 17 |
the advent of | 17 |
of this technology | 17 |
and there is | 17 |
around the world | 17 |
broad range of | 17 |
significant difference was | 17 |
antibodies and their | 17 |
of ebola virus | 17 |
accordance with the | 17 |
the association of | 17 |
hemolytic transfusion reactions | 17 |
the requirement for | 17 |
of action of | 17 |
secreting antibody of | 17 |
from the serum | 17 |
be carried out | 17 |
infected cells by | 17 |
by centrifugation at | 17 |
was collected from | 17 |
carried out on | 17 |
in the platelet | 17 |
been made in | 17 |
are in the | 17 |
binding of antibody | 17 |
most commonly used | 17 |
for the selection | 17 |
is found in | 17 |
was not detected | 17 |
to this end | 17 |
of igg molecules | 17 |
of the global | 17 |
whole blood and | 17 |
and activation of | 17 |
acute and chronic | 17 |
the possibility to | 17 |
and days after | 17 |
may be useful | 17 |
and after the | 17 |
an attempt to | 17 |
in the region | 17 |
the near future | 17 |
validation of the | 17 |
bovine serum albumin | 17 |
response to sars | 17 |
regardless of the | 17 |
can be easily | 17 |
igg antibodies to | 17 |
was performed to | 17 |
at a time | 17 |
is still a | 17 |
even though the | 17 |
easy to use | 17 |
expressed as the | 17 |
blood transfusion is | 17 |
with antibodies to | 17 |
on the quality | 17 |
was higher than | 17 |
were pooled and | 17 |
which in turn | 17 |
by binding to | 17 |
prevalence of the | 17 |
this type of | 17 |
is consistent with | 17 |
more sensitive than | 17 |
of the alternative | 17 |
management of patients | 17 |
cells secreting antibody | 17 |
the blood of | 17 |
screening of blood | 17 |
test for the | 17 |
of a high | 17 |
advances in the | 17 |
antibodies to ccv | 17 |
the united kingdom | 17 |
whole blood donors | 17 |
important in the | 17 |
antibodies that can | 17 |
to produce a | 17 |
as a possible | 17 |
whole blood or | 17 |
a minority of | 17 |
to measure the | 17 |
of the mab | 17 |
two doses of | 17 |
availability of blood | 17 |
useful for the | 17 |
used to determine | 17 |
the experience of | 17 |
antibodies binding to | 17 |
be isolated from | 17 |
a broad range | 17 |
a member of | 17 |
vascular endothelial growth | 17 |
to remove the | 17 |
to obtain a | 17 |
peripheral blood lymphocytes | 17 |
proportional to the | 17 |
parts of the | 17 |
our results show | 17 |
in this group | 17 |
incubated for min | 17 |
be noted that | 17 |
high titers of | 17 |
sensitive detection of | 17 |
the first transfusion | 17 |
antibodies could be | 17 |
more common in | 17 |
a very low | 17 |
the intensive care | 17 |
lower in the | 17 |
developed for the | 17 |
cells in vitro | 17 |
expected to be | 16 |
this is not | 16 |
igy and igg | 16 |
interaction with the | 16 |
important for the | 16 |
the binding site | 16 |
they did not | 16 |
final concentration of | 16 |
regarding the use | 16 |
number of samples | 16 |
fact that the | 16 |
increased susceptibility to | 16 |
to analyze the | 16 |
contributed to the | 16 |
and use of | 16 |
the validity of | 16 |
in this context | 16 |
should be noted | 16 |
not present in | 16 |
internal and external | 16 |
as a single | 16 |
the incorporation of | 16 |
so as to | 16 |
have been the | 16 |
found to have | 16 |
be regarded as | 16 |
plasma therapy in | 16 |
the evolution of | 16 |
of c b | 16 |
the usage of | 16 |
different animal species | 16 |
on the market | 16 |
by increasing the | 16 |
account for the | 16 |
the blood products | 16 |
antibodies to a | 16 |
in the two | 16 |
the therapeutic potential | 16 |
side effects of | 16 |
induced by a | 16 |
the receptor binding | 16 |
of the antigens | 16 |
mean value of | 16 |
presence of an | 16 |
are difficult to | 16 |
to the immune | 16 |
with the human | 16 |
the membrane was | 16 |
of the initial | 16 |
therapy has been | 16 |
was selected for | 16 |
serum of the | 16 |
dengue virus infection | 16 |
the h d | 16 |
significant differences between | 16 |
been applied to | 16 |
of blood donor | 16 |
and distribution of | 16 |
for in vitro | 16 |
stability of the | 16 |
dendritic cells and | 16 |
determined by elisa | 16 |
these results indicate | 16 |
significantly higher than | 16 |
to be an | 16 |
infection with a | 16 |
by the fda | 16 |